Dr. Susanne van Veluw is an Assistant Professor in the department of Neurology at Massachusetts General Hospital, Harvard Medical School in Boston. She obtained her MSc in clinical neuroscience at the Free University in Amsterdam, and her PhD at the University Medical Center in Utrecht, the Netherlands. During her PhD she used high field 7T MRI and neuropathological examination in older individuals to study the impact of microvascular pathology on brain structure and function. For her post-doctoral training, she moved to Boston to work with Drs. Steven Greenberg and Brian Bacskai on microvascular pathology in patients with cerebral amyloid angiopathy. Her lab uses translational imaging approaches, ranging from ex vivo MRI-guided histopathology in human brain tissue to in vivo two-photon microscopy in mice to better understand the pathophysiology of cerebral amyloid angiopathy. For this project, funded by the BrightFocus Foundation, her lab will collaborate with Dr. David Holtzman from Washington University in St. Louis, who developed the anti-ApoE immunotherapy strategy to clear amyloid beta from the brain.
Massachusetts General Hospital